GPs & Medical Cannabis
UK legislation only permits a specialist doctor to initiate a script for a cannabis-based medical product. However, GPs may be expected to continue monitoring and prescribing under a shared-care agreement.
THUS FAR, GPS HAVE LARGELY BEEN LEFT OUT OF THE CONVERSATION BY NOT BEING ALLOWED TO INITIATE SCRIPTS
AND OVERSEE MEDICAL CANNABIS TREATMENTS, DESPITE BEING AT THE FRONTLINE OF PATIENT CARE AND INTERACTING DIRECTLY WITH PATIENTS PERHAPS MORE THAN OTHER
WITH THE RIGHT APPROACH, GENERAL PRACTITIONERS CAN PLAY A PIVOTAL AND ESSENTIAL ROL
Cannabis based medical products have been demonstrated to be effective as an alternative or as an add-on treatment for a number of common conditions including:
Spasticity in MS
Nausea and vomiting in chemotherapy
Keeping up-to-date with advances in medicine and science is a professional duty and also forms part of the GMC Good Medical Practice Guidelines. Cannabis-based medicines are no exception, as this duty is not limited to single pharmaceutical agents but all evidence-based therapies appropriate to a patient’s care. GP’s need to be further equipped in their understanding of the Endocannabinoid system, especially as more patients become aware of cannabis medicine as a potential option.
Here at the Primary Care Cannabis Network, we want to make it that much easier for GPs to be kept up-to-date; by providing key insights, recent developments and providing a platform for discussion.